SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-21-017827
Filing Date
2021-04-06
Accepted
2021-04-06 16:36:35
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 abio-424b5.htm 424B5 809497
2 GRAPHIC gp5m5bivuamv000005.jpg GRAPHIC 99330
3 GRAPHIC gp5m5bivuamv000002.jpg GRAPHIC 99330
4 GRAPHIC gp5m5bivuamv000004.jpg GRAPHIC 2926
5 GRAPHIC gp5m5bivuamv000003.jpg GRAPHIC 8908
6 GRAPHIC gp5m5bivuamv000001.jpg GRAPHIC 2926
  Complete submission text file 0001564590-21-017827.txt   1104972
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254585 | Film No.: 21809537
SIC: 2835 In Vitro & In Vivo Diagnostic Substances